SAFEGUARD MEDICAL
Safeguard Medical, headquartered in Great Britain, is a leading provider in the medical supplies industry, specialising in innovative solutions for emergency medical services and trauma care. Founded in 2015, the company has rapidly established itself as a key player in the market, with a focus on enhancing patient outcomes through high-quality products and training. With a diverse range of offerings, including advanced trauma kits and medical training programmes, Safeguard Medical stands out for its commitment to quality and reliability. The company operates extensively across Europe and North America, catering to both professional and civilian markets. Notable achievements include partnerships with various emergency services, underscoring its reputation for excellence in the field. Safeguard Medical continues to drive advancements in medical preparedness, ensuring that first responders are equipped with the best tools available.
DitchCarbon Score
How does SAFEGUARD MEDICAL's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SAFEGUARD MEDICAL's score of 16 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
SAFEGUARD MEDICAL's reported carbon emissions
In 2023, SAFEGUARD MEDICAL reported total carbon emissions of approximately 6,800,000,000 kg CO2e across all scopes. This includes about 113,528,000 kg CO2e from Scope 1 emissions and approximately 139,701,000 kg CO2e from Scope 2 emissions. The Scope 3 emissions remained consistent at about 6,800,000,000 kg CO2e, indicating a significant area for potential improvement. Comparatively, in 2022, the company recorded about 118,000,000 kg CO2e in Scope 1 and approximately 171,000,000 kg CO2e in Scope 2 emissions, with Scope 3 emissions also at about 6,800,000,000 kg CO2e. This reflects a slight reduction in Scope 1 and Scope 2 emissions in 2023. Currently, SAFEGUARD MEDICAL has not disclosed any specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of defined reduction strategies suggests an opportunity for the company to enhance its climate commitments and address its substantial Scope 3 emissions, which represent the largest portion of its carbon footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 118,000,000 | 000,000,000 |
| Scope 2 | 171,000,000 | 000,000,000 |
| Scope 3 | 6,800,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
SAFEGUARD MEDICAL is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
